Eli Lilly Files Infringement Complaint Against Par Pharmaceutical

April 24, 2017 – Plaintiffs Eli Lilly and Company, Eli Lilly Export S.A., and Acrux DDS Pty Ltd. filed a complaint alleging infringement by Defendants Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. of patents concerning the pharmaceutical drug product Axiron®. The patents-at-issue are U.S. Patent Nos. 8,177,449, 8,419,307, 8,807,861, and 9,289,586, titled “Spreading implement”; and 8,435,944, 8,993,520, and 9,180,194, titled “Method and composition for transdermal drug delivery.” The case is pending in the United States District Court for the District of Delaware, and is number 1-17-cv-00456.

By: Katherine E. Adams

View Attachment (PDF)